Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Breast Mammography Benefits Are Minimal For Women 40-49 – Annals Study

This article was originally published in The Gray Sheet

Executive Summary

Mammography is not likely to reduce the number of breast cancer deaths by more than 20% in women ages 40-49, according to results from the Canadian National Breast Screening Study-1

You may also be interested in...



Routine Mammography Not Vital For Women In Their 40’s – NEJM Study

The risks of routine mammography screening for breast cancer detection among women ages 40-49 may outweigh the potential benefits, according to a study in the April 24 New England Journal of Medicine.

Routine Mammography Not Vital For Women In Their 40’s – NEJM Study

The risks of routine mammography screening for breast cancer detection among women ages 40-49 may outweigh the potential benefits, according to a study in the April 24 New England Journal of Medicine.

Cytyc Prepares To Launch ThinPrep Imager; Women’s Health Recap For 2002

Cytyc's ThinPrep and TriPath's SurePath liquid-based cytology Pap tests could receive a boost in 2003 from a positive NICE technology assessment review

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017102

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel